Partial evaluation of fidelity in the implementation of tuberculosis preventive treatment in people living with HIV in Paraguay: an implementation science study

Authors

DOI:

https://doi.org/10.17843/rpmesp.2026.432.15170

Keywords:

Mycobacterium Tuberculosis, HIV Infections, Coinfections, Implementation Science, Paraguay

Abstract

Objectives. To evaluate self-reported adherence to the essential components of tuberculosis preventive treatment (TPT), as an estimate of partial implementation fidelity, and to explore the moderating factors influencing its implementation in two referral services in the Central Department, Paraguay. Materials and methods. A descriptive observational mixed-methods study with a convergent parallel design  (January–May 2023) was conducted in two referral  centers for people living with HIV. Partial  implementation fidelity was estimated through self-reported adherence to the content and frequency  dimensions of TPT implementation according to the  National Tuberculosis Guide. Semi-structured interviews were conducted with key stakeholders to identify  barriers and facilitators. Results. 11/13 physicians and 10 key stakeholders participated. Overall TPT fidelity was  low (50.0%). Adherence to content was moderate (64.2%), while adherence to frequency was low (31.3%), evidencing a gap between perceived importance and clinical practice. The awareness/education component showed the lowest performance. The main barriers were identified in the internal environment, including organizational fragmentation between TB/HIV  programs, limited resources, absence of operational  protocols, and communication deficiencies. At the  individual level, erroneous beliefs and low self-efficacy  were identified. As facilitators, national normative  alignment and the willingness of stakeholders to  strengthen implementation were observed. Conclusions.
Low fidelity reflects mainly organizational and process failures, which highlights the need for facilitation strategies, interprogrammatic articulation, and capacity strengthening to achieve sustained implementation.

Downloads

Download data is not yet available.

References

World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention. Tuberculosis preventive treatment [Internet]. Geneva: World Health Organization; 2021 [cited 2023 Apr 25]. Available from: https://iris.paho.org/handle/10665.2/55801.

Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. Lancet. 2012;379(9822):1368–81. doi: 10.1016/S0140-6736(11)61698-5.

World Health Organization. Global tuberculosis report 2021 [Internet]. Geneva: World Health Organization; 2021 [cited 2026 Feb 6]. Available from: https://www.who.int/publications/i/item/9789240037021.

Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8(1):19. doi: 10.1016/S2213-2600(19)30418-7.

Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. Lancet HIV. 2020;7(5):e319–20. doi: 10.1016/S2352-3018(20)30109-0.

World Health Organization. Global tuberculosis report 2022 [Internet]. Geneva: World Health Organization; 2022 [cited 2023 Apr 25]. Available from: https://www.who.int/publications/i/item/9789240061729.

World Health Organization. Ending tuberculosis: progress in implementing the global strategy and targets for tuberculosis prevention, care and control after 2015 (End TB Strategy) [Internet]. Geneva: World Health Organization; 2019 [cited 2023 Apr 25]. Available from: https://apps.who.int/gb/ebwha/pdf_files/EB146/B146_10-sp.pdf.

Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in the context of the Sustainable Development Goals. Lancet. 2018;392(10157):1431–46. doi: 10.1016/S2213-2600(18)30057-2.

Atkinson A, Kraus D, Banholzer N, Miro JM, Reiss P, Kirk O, et al. HIV replication and tuberculosis risk among people living with HIV in Europe: a multicohort analysis, 1983–2015. PLoS One. 2024;19(10):e0312035. doi: 10.1371/journal.pone.0312035.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, et al. Building a tuberculosis-free world: the Lancet Commission on tuberculosis. Lancet. 2019;393(10178):1331–84. doi: 10.1016/S0140-6736(19)30024-8.

Pan American Health Organization. Coinfection TB/HIV: regional clinical guideline. Update 2017 [Internet]. Washington (DC): Pan American Health Organization; 2017 [cited 2023 Apr 25]. Available from: https://iris.paho.org/bitstream/handle/10665.2/34855/9789275319857_spa.pdf.

Ministerio de Salud Pública y Bienestar Social. Guía nacional para el manejo de los servicios de salud locales, distritales, regionales y unidades de salud de la familia. Tuberculosis [Internet]. Asunción: MSPBS; 2018 [cited 2023 Apr 25]. Available from: https://www.medbox.org/pdf/628dfcfe50c49a328c004252.

Moreno R, Ravasi G, Avedillo P, Lopez R. Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean. Rev Panam Salud Publica. 2020;44:e43. doi: 10.26633/RPSP.2020.43.

Elbehiry A, Marzouk E, Edrees HM, AlShaqi R, Ellethy AT, Alzaben F, et al. Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science. Front Med. 2025;12:1596579. doi: 10.3389/fmed.2025.1596579.

Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain S. A conceptual framework for implementation fidelity. Implement Sci. 2007;2:40. doi: 10.1186/1748-5908-2-40.

Damschroder LJ, Reardon CM, Opra Widerquist MA, Lowery J. Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR outcomes addendum. Implement Sci. 2022;17:7. doi: 10.1186/s13012-021-01181-5.

Narh-Bana SA, Kawonga M, Chirwa ED, Ibisomi L, Bonsu F, Chirwa TF. Fidelity of implementation of TB screening guidelines by health providers at selected HIV clinics in Ghana. PLoS One. 2021;16(9):e0257486. doi: 10.1371/journal.pone.0257486.

Toomey E, Matthews J, Hurley DA. Using mixed methods to assess fidelity of delivery and its influencing factors in a complex self-management intervention for people with osteoarthritis and low back pain. BMJ Open. 2017;7:e015452. doi: 10.1136/bmjopen-2016-015452.

Borrelli B, Sepinwall D, Bellg AJ, Breger R, DeFrancesco C, Sharp DL, et al. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol. 2005;73(5):852–60.

Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76. doi: 10.1007/s10488-010-0319-7.

Nurjono M, Shrestha P, Ang IYH. Implementation fidelity of a strategy to integrate service delivery: learnings from a transitional care program for individuals with complex needs in Singapore. BMC Health Serv Res. 2019;19:177. doi: 10.1186/s12913-019-3980-x.

Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi: 10.1186/1748-5908-4-50.

García-Fernández L, Benites C, Huamán B. Barreras para el acceso a la atención integral de las personas afectadas por la coinfección por tuberculosis y virus de inmunodeficiencia humana en Perú, 2010–2015. Rev Panam Salud Publica. 2017;41:e23. Available from: https://iris.paho.org/handle/10665.2/34032.

Selimin DS, Ismail A, Ahmad N, Ismail R, Mohd Azman NF, Azman A. Tuberculosis treatment outcome in patients with TB-HIV coinfection in Kuala Lumpur, Malaysia. J Trop Med. 2021;2021:9923378. doi: 10.1155/2021/9923378.

Breitenstein SM, Gross D, Garvey CA, Hill C, Fogg L, Resnick B. Implementation fidelity in community-based interventions. Res Nurs Health. 2010;33(2):164–73. doi: 10.1002/nur.20373.

Duarte-Zoilán DGA. La ciencia de la investigación de la implementación como herramienta para las investigaciones en salud pública. Med Clínica Soc. 2022;6(3):87–8. doi: 10.52379/mcs.v6i3.260.

Published

2026-06-22

Issue

Section

Original Article

How to Cite

1.
Duarte-Zoilan D, Arbeláez Montoya MP, Benjumea-Bedoya D. Partial evaluation of fidelity in the implementation of tuberculosis preventive treatment in people living with HIV in Paraguay: an implementation science study. Rev Peru Med Exp Salud Publica [Internet]. 2026 Jun. 22 [cited 2026 Jul. 10];43(2):160-70. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/15170

Most read articles by the same author(s)